Abstract: The present invention relates to methods of detecting, diagnosing and distinguishing between demyelinating diseases such as Multiple Sclerosis. The present invention also relates to methods of treating, and peptides for use in the treatment of, demyelinating diseases such as Multiple Sclerosis.
Type:
Grant
Filed:
November 1, 2017
Date of Patent:
September 6, 2022
Assignee:
MATN SCIENTIFIC LIMITED
Inventors:
Mahmoud Sedaghati, Mahsa Sedaghati, Tina Sedaghati